Literature DB >> 20441425

Complementary and alternative medicine for the treatment of multiple sclerosis.

Vijayshree Yadav1, Lynne Shinto, Dennis Bourdette.   

Abstract

Multiple sclerosis (MS) is a chronic disabling disease of the CNS that affects people during early adulthood. Despite several US FDA-approved medications, the treatment options in MS are limited. Many people with MS explore complementary and alternative medicine (CAM) treatments to help control their MS and treat their symptoms. Surveys suggest that up to 70% of people with MS have tried one or more CAM treatment for their MS. People with MS using CAM generally report deriving some benefit from the therapies. The CAM therapies most frequently used include diet, omega-3 fatty acids and antioxidants. There is very limited research evaluating the safety and effectiveness of CAM in MS. The most promising among CAM therapies that warrant further investigation are a low-fat diet, omega-3 fatty acids, lipoic acid and vitamin D supplementation as potential anti-inflammatory and neuroprotective agents in both relapsing and progressive forms of MS. There is very limited research evaluating the safety and effectiveness of CAM in MS. However, in recent years, the NIH and the National MS Society have been actively supporting the research in this very important area.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20441425      PMCID: PMC2901236          DOI: 10.1586/eci.10.12

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  160 in total

1.  Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6.

Authors:  S L Hauser; T H Doolittle; R Lincoln; R H Brown; C A Dinarello
Journal:  Neurology       Date:  1990-11       Impact factor: 9.910

2.  Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

Authors:  T A Yednock; C Cannon; L C Fritz; F Sanchez-Madrid; L Steinman; N Karin
Journal:  Nature       Date:  1992-03-05       Impact factor: 49.962

3.  Serum cytokine levels in chronic progressive multiple sclerosis: interleukin-2 levels parallel tumor necrosis factor-alpha levels.

Authors:  J L Trotter; K G Collins; R C van der Veen
Journal:  J Neuroimmunol       Date:  1991-07       Impact factor: 3.478

4.  Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction.

Authors:  S M Rao; G J Leo; L Bernardin; F Unverzagt
Journal:  Neurology       Date:  1991-05       Impact factor: 9.910

5.  1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis.

Authors:  J M Lemire; D C Archer
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

Review 6.  Environmental factors that influence the cutaneous production of vitamin D.

Authors:  M F Holick
Journal:  Am J Clin Nutr       Date:  1995-03       Impact factor: 7.045

7.  The impact of fatigue on patients with multiple sclerosis.

Authors:  J D Fisk; A Pontefract; P G Ritvo; C J Archibald; T J Murray
Journal:  Can J Neurol Sci       Date:  1994-02       Impact factor: 2.104

8.  Cytokine secretion by multiple sclerosis monocytes. Relationship to disease activity.

Authors:  R A Rudick; R M Ransohoff
Journal:  Arch Neurol       Date:  1992-03

9.  Glutathione reductase and lipoamide dehydrogenase have opposite stereospecificities for alpha-lipoic acid enantiomers.

Authors:  U Pick; N Haramaki; A Constantinescu; G J Handelman; H J Tritschler; L Packer
Journal:  Biochem Biophys Res Commun       Date:  1995-01-17       Impact factor: 3.575

10.  Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids.

Authors:  V Gallai; P Sarchielli; A Trequattrini; M Franceschini; A Floridi; C Firenze; A Alberti; D Di Benedetto; E Stragliotto
Journal:  J Neuroimmunol       Date:  1995-02       Impact factor: 3.478

View more
  23 in total

Review 1.  Therapeutic Yoga: Symptom Management for Multiple Sclerosis.

Authors:  Kim A Rogers; Megan MacDonald
Journal:  J Altern Complement Med       Date:  2015-08-13       Impact factor: 2.579

Review 2.  Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis.

Authors:  Insha Zahoor; Shailendra Giri
Journal:  Clin Rev Allergy Immunol       Date:  2021-04       Impact factor: 8.667

Review 3.  The influence of nutritional factors on the prognosis of multiple sclerosis.

Authors:  Gloria von Geldern; Ellen M Mowry
Journal:  Nat Rev Neurol       Date:  2012-10-02       Impact factor: 42.937

4.  Complementary and Alternative Medicine Usage by Multiple Sclerosis Patients: Results from a Prospective Clinical Study.

Authors:  Soohyun Kim; Lawrence Chang; Bianca Weinstock-Guttman; Sirin Gandhi; Dejan Jakimovski; Ellen Carl; Robert Zivadinov; Murali Ramanathan
Journal:  J Altern Complement Med       Date:  2018-03-02       Impact factor: 2.579

5.  Patterns of dietary and herbal supplement use by multiple sclerosis patients.

Authors:  Kerri O'Connor; Bianca Weinstock-Guttman; Ellen Carl; Colleen Kilanowski; Robert Zivadinov; Murali Ramanathan
Journal:  J Neurol       Date:  2011-09-06       Impact factor: 4.849

6.  Kombucha ameliorates experimental autoimmune encephalomyelitis through activation of Treg and Th2 cells.

Authors:  Dariush Haghmorad; Esmaeil Yazdanpanah; Bizhan Sadighimoghaddam; Bahman Yousefi; Pegah Sahafi; Narges Ghorbani; Ali Rashidy-Pour; Parviz Kokhaei
Journal:  Acta Neurol Belg       Date:  2020-08-18       Impact factor: 2.396

7.  Promoting return of function in multiple sclerosis: An integrated approach.

Authors:  Mar Gacias; Patrizia Casaccia
Journal:  Mult Scler Relat Disord       Date:  2013-10-01       Impact factor: 4.339

Review 8.  Complementary and alternative therapies in multiple sclerosis: a systematic literature classification and analysis.

Authors:  Goli Arji; Hossein Rezaeizadeh; Abdolrreza Naser Moghadasi; Mohammad Ali Sahraian; Mehrdad Karimi; Mojtaba Alizadeh
Journal:  Acta Neurol Belg       Date:  2022-01-21       Impact factor: 2.396

9.  Household paired design reduces variance and increases power in multi-city gut microbiome study in multiple sclerosis.

Authors: 
Journal:  Mult Scler       Date:  2020-06-26       Impact factor: 6.312

10.  Use of Complementary and Alternative Medicine among People with Multiple Sclerosis in the Nordic Countries.

Authors:  L Skovgaard; P H Nicolajsen; E Pedersen; M Kant; S Fredrikson; M Verhoef; D W Meyrowitsch
Journal:  Autoimmune Dis       Date:  2012-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.